These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 7510566
1. Postextrasystolic ischemic T wave. A possible silent ischemia. Cotoi S, Carasca E, Podoleanu D. Rom J Intern Med; 1993; 31(3):173-5. PubMed ID: 7510566 [Abstract] [Full Text] [Related]
2. Postextrasystolic changes in ventricular depolarization (electrocardiographic observations). Cotoi S, Dobreanu D, Caraşca E. Rom J Intern Med; 1995; 33(3-4):199-203. PubMed ID: 8646192 [Abstract] [Full Text] [Related]
3. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure. Mahgoub AA, El-Medany AH, Abdulatif AS. Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557 [Abstract] [Full Text] [Related]
4. [The emergence of silent myocardial ischemia as the manifestation of the nitrate withdrawal syndrome in patients with ischemic heart disease]. Martsevich SIu, Kutishenko NP, Metelitsa VI. Ter Arkh; 1996 Jun; 68(5):51-4. PubMed ID: 9082601 [Abstract] [Full Text] [Related]
5. ECG of the month. Clearing the air. Postextrasystolic T-wave changes. Martinez-Lopez JI. J La State Med Soc; 1989 Feb; 141(2):7, 10-1. PubMed ID: 2468729 [No Abstract] [Full Text] [Related]
6. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort]. Alimova EV, Martsevich SIu, Kutishenko NP, Metelitsa VI. Ter Arkh; 1997 Feb; 69(12):37-40. PubMed ID: 9503532 [Abstract] [Full Text] [Related]
7. [The clinico-immunological aspects of ventricular extrasystole in ischemic heart disease]. Nikitin AV, Zemskov AM, Zemskov VM, Gusmanov VA, Evstratova EF. Ter Arkh; 1992 Feb; 64(9):44-7. PubMed ID: 1282739 [No Abstract] [Full Text] [Related]
8. [The anti-arrhythmia action of tiracizine in patients with ischemic heart disease and decreased myocardial contractile function]. Mishin IuI, Kliachkina IL, Ivashkin VT, Min'kova TI, Bannikova SD. Voen Med Zh; 1997 Jun; 318(6):44-7. PubMed ID: 9412062 [No Abstract] [Full Text] [Related]
9. [Clinical significance of postextrasystolic changes in the T wave]. Uglesić A. Lijec Vjesn; 1970 Jun; 92(9):1021-32. PubMed ID: 4104103 [No Abstract] [Full Text] [Related]
10. [The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy]. Palazzuoli V, Mondillo S, Faglia S, D'Aprile N, Camporeale A, Gennari C. Clin Ter; 1993 Feb; 142(2):155-9. PubMed ID: 7682488 [Abstract] [Full Text] [Related]
11. [Use of the preparation Iso Mack Retard 60 mg I 120 mg in the treatment of patients with advanced ischemic heart disease]. Markiewicz M, Jach A, Wysokiński A. Wiad Lek; 1992 Nov; 45(21-22):803-5. PubMed ID: 1299035 [Abstract] [Full Text] [Related]
12. The natural history of postischemic T-wave inversion: a predictor of poor short-term prognosis? Simon K, Hackett D, Szelier A, Szabó P, Szépvölgyi A, Turi T, Sereg M, Szatmáry L. Coron Artery Dis; 1994 Nov; 5(11):937-42. PubMed ID: 7719526 [Abstract] [Full Text] [Related]
13. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients]. Dunaev VV, Kraĭdashenko OV, Berezin AE. Eksp Klin Farmakol; 1996 Nov; 59(1):21-3. PubMed ID: 8704625 [Abstract] [Full Text] [Related]
14. Ischemically mediated sustained monomorphic ventricular tachycardia. Resolution with anti-ischemic therapy. Peters RW, Kim HJ, Buser GA, Gold MR. Chest; 1993 Nov; 104(5):1613-4. PubMed ID: 8222838 [Abstract] [Full Text] [Related]
15. [Proceedings: Identification of reversible-asynergic myocardial regions by means of postextrasystolic potentiation (PESP) and application of nitrate]. Loracher C, Dacian S, Rudolph W. Z Kardiol; 1975 Nov; Suppl 2():55. PubMed ID: 53952 [No Abstract] [Full Text] [Related]
16. Evaluation of postextrasystolic T wave alterations in identification of patients with coronary artery disease or left ventricular dysfunction. Leachman DR, Dehmer GJ, Firth BG, Markham RV, Winniford MD, Hillis LD. Am Heart J; 1981 Oct; 102(4):658-63. PubMed ID: 6169269 [Abstract] [Full Text] [Related]
17. [The effect of carbon dioxide baths on the physical work capacity and extrasystole of patients with ischemic heart disease and stable stenocardia]. Klemenkov SV, Davydova OB, Klemenkova ZhE, Makushkin AK. Vopr Kurortol Fizioter Lech Fiz Kult; 1995 Oct; (4):3-5. PubMed ID: 8779184 [Abstract] [Full Text] [Related]
18. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography]. Arushanian EB, Shamliian TA. Eksp Klin Farmakol; 1996 Oct; 59(2):24-6. PubMed ID: 8974558 [Abstract] [Full Text] [Related]
19. [Use of olicard retard in patients with stable angina of low effort in an outpatient setting]. Alekseeva NP, Runikhina NK, Lastovetskaia VI, Larin VG. Klin Med (Mosk); 2000 Oct; 78(8):72-4. PubMed ID: 11019532 [Abstract] [Full Text] [Related]
20. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina]. Lupanov VP, Alekseeva IA, Vasil'eva NN, Komar OA, Romasiuk SS, Naumov VG. Ter Arkh; 2000 Oct; 72(9):33-6. PubMed ID: 11076413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]